From Cell to Cellestia: Building a successful BioTech startup

Dr. Rajwinder Lehal co-founded Cellestia Biotech AG in 2014 and serves as its Chief Scientific Officer. Mr. Lehal has more than 13 years of experience in cancer research. Since 2007, Dr. Lehal has been working at the Swiss Institute for Experimental Cancer Research-EPFL, where he established a drug discovery platform to discover and develop novel anti- cancer therapeutics. Dr. Lehal is the recipient of several academic awards including the Canadian Genetic Disease Network, the American Association for Cancer Research-Scholar in Training award, University of Toronto fellowship, Frank Fletcher Memorial scholarship for cancer research and Al and Hannah Peryl Graduate student scholarship. Based on his drug discovery research, he was awarded INNOGRANT and ENABLE grant by the Vice Presidency for Innovation and Technology Transfer at EPFL.